๐๐ก๐๐ซ๐ฆ๐๐๐ฒ ๐๐ง๐ ๐๐จ๐ข๐ฌ๐จ๐ง๐ฌ ๐๐จ๐๐ซ๐ ๐๐ง๐๐๐ซ๐ญ๐๐ค๐๐ฌ ๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐ ๐๐๐ฏ๐ข๐๐ฐ ๐๐จ๐ซ ๐๐ฅ๐ข๐ ๐ง๐ฆ๐๐ง๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐๐ฅ๐ญ๐ก ๐๐จ๐๐ฅ๐ฌ, 6th November 2023
Mombasa, KENYA โ The Pharmacy and Poisons Board (PPB) is currently immersed in a vital strategic review, with a strong emphasis on result-oriented management and alignment with the governmentโs Bottom-up Economic agenda (BETA) and Universal Health Coverage. This week, the PPBโs Board of Directors and management have convened in Mombasa to ensure their 2020-2025 strategic plan harmonizes with national objectives.
Dr. Charles Githinji, Chairman of the PPB, has emphasized several key priorities, including achieving WHO Maturity Level 3, implementing result-based management, addressing issues related to unregistered outlets, resource mobilization, and promoting teamwork. These priorities are aimed at aligning the PPB with national healthcare objectives.
Additionally, Dr. F.M. Siyoi, the CEO of the PPB, has stressed the need for change and has provided assurance that the management team is well-prepared for this transformative journey. The pharma sectorโs vital role in ensuring the quality, safety, and efficacy of healthcare products is paramount to the nationโs health and overall well-being.